Article: Blood glucose monitor boosts MiniMed.

MiniMed Inc. is awaiting Food and Drug Administration approval for a revolutionary glucose sensor that will give diabetics the most precise way yet of monitoring their blood sugar levels.

An FDA advisory panel recommended approval of the Continuous Glucose Monitoring System in February. The final green light could come any time in the next few weeks. according to Alfred Mann, founder and CEO of the Sylmar-based medical technology manufacturer.

"Our ultimate objective is to create an artificial pancreas," Mann said.

The glucose monitor is a big step in that direction. It is the first home testing device designed to allow diabetics to continuously ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!